scholarly journals Revisiting The Simulation Evidence for the Incremental Cost-Effectiveness of Breast Cancer Screening of Average-Risk Women

2015 ◽  
Vol 18 (7) ◽  
pp. A453
Author(s):  
JF O’Mahony
2020 ◽  
Author(s):  
Talha Tahir ◽  
Melanie Mitsui Wong ◽  
Rabia Tahir ◽  
Michael Mitsui Wong

AbstractIntroductionMammography-based breast cancer screening is an important aspect of female breast cancer prevention within the Canadian healthcare system. The current literature on female breast cancer screening is largely focused on the health outcomes that result from screening. There is comparatively little data on the cost-effectiveness of the screening. Therefore, this paper sought to conduct a systematic review of the literature on the cost effectiveness of mammography-based breast cancer screening within female Canadian populations.Materials and methodsA systematic review was performed in the PubMed database to identify all studies published within the last 10 years that addressed breast cancer screening and evaluate cost-effectiveness in a Canadian population.ResultsThe search yielded five studies for inclusion, only three of which were applicable to average-risk Canadian women. The benefits of mortality reduction rose approximately linearly with costs, while costs were linearly dependent on the number of lifetime screens per woman. Moreover, triennial screening for average-risk women aged 50-69 years was found to be the most cost-effective in terms of cost per quality adjusted life year. The use of MRI in conjunction with mammography for women with the BRCA 1/2 mutation was found to be cost-effective while annual mammography-based screening for women with dense breasts was found to be cost-ineffective.ConclusionIn spite of the growing interest to enhance breast cancer screening programs, analyses of the cost-effectiveness of mammography-based screening within Canadian populations are scarcely reported and have heterogeneous methodologies. The existing data suggests that Canada’s current breast cancer screening policy to screen average-risk women aged 50-74, biennially or triennially is cost-effective. These findings could be of interest to health policy makers when making decisions regarding resource allocation; however, further studies in this field are required in order to make stronger recommendations regarding cost-effectiveness.


2008 ◽  
Vol 148 (1) ◽  
pp. 1 ◽  
Author(s):  
Anna N.A. Tosteson ◽  
Natasha K. Stout ◽  
Dennis G. Fryback ◽  
Suddhasatta Acharyya ◽  
Benjamin A. Herman ◽  
...  

2012 ◽  
Author(s):  
Gerald Gartlehner ◽  
Kylie Thaler ◽  
Dominik Berzaczy ◽  
Angela Kaminski ◽  
Andrea Chapman ◽  
...  

2017 ◽  
Vol 14 (9) ◽  
pp. 1137-1143 ◽  
Author(s):  
Debra L. Monticciolo ◽  
Mary S. Newell ◽  
R. Edward Hendrick ◽  
Mark A. Helvie ◽  
Linda Moy ◽  
...  

2017 ◽  
pp. 1-10 ◽  
Author(s):  
Elizabeth J. Siembida ◽  
Archana Radhakrishnan ◽  
Sarah A. Nowak ◽  
Andrew M. Parker ◽  
Craig Evan Pollack

Purpose Physician reminders have successfully increased rates of mammography. However, considering recent changes to breast cancer screening guidelines that disagree on the optimal age to start and stop mammography screening, we sought to examine the extent to which reminders have been deployed for breast cancer screening targeting younger and older patients. Methods A mailed survey was sent to a national sample of 2,000 primary care physicians between May and September 2016. Physicians were asked whether they received reminders to screen women in various age groups (40 to 44, 45 to 49, and ≥ 75 years), the organizational screening guidelines they trusted most, and whether they recommended routine breast cancer screening to average-risk women in the different age groups. Using regression models, we assessed the association between reminders and physician screening recommendations, controlling for physician and practice characteristics, and evaluated whether the association varied by the guidelines they trusted. Results A total of 871 physicians responded (adjusted response rate, 52.3%). Overall, 28.9% of physicians reported receiving reminders for patient ages 40 to 44 years, 32.5% for patient ages 45 to 49 years, and 16.5% for patient ages ≥ 75 years. Receiving reminders significantly increased the likelihood of physicians recommending mammography screening. In adjusted analyses, 84% (95% CI, 77% to 90%) of physicians who received reminders recommended screening for women ages ≥ 75 versus 65% (95% CI, 62% to 69%) of those who did not receive reminders. The associations between reminders and screening recommendations remained consistent regardless of which guidelines physicians reported trusting. Conclusion Reminders were significantly associated with increases in physician screening recommendations for mammography, underscoring the need for careful implementation in scenarios where guidelines are discordant.


2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Yoshiki Ishikawa ◽  
Kei Hirai ◽  
Hiroshi Saito ◽  
Jun Fukuyoshi ◽  
Akio Yonekura ◽  
...  

An amendment to this paper has been published and can be accessed via the original article.


Sign in / Sign up

Export Citation Format

Share Document